4079 |
Update on Antithrombotic Therapy After ACS/PCI: Recent Advances and Innovations in Drugs and Strategy |
Deepak Bhatt |
Apr. 12. 21 |
4078 |
The Future of PCI: Contemporary Optimal Indication, Technology, and Outlook |
Robert A. Byrne |
Apr. 12. 21 |
4077 |
Managing LDL-C with Praluent: Identifying the Patients, Optimizing the Outcomes |
Yongwhi Park |
Apr. 12. 21 |
4076 |
From Sustainable Lipid Management to Life-Saving CV Protection for ACS Patients |
Ki Hoon Han |
Apr. 12. 21 |
4075 |
Right Time to Reverse Cardiac Remodeling with ARNI |
Jeong Su Kim |
Apr. 12. 21 |
4074 |
Reinforce Strategies to Improve Outcomes in POST-MI Heart Failure |
Do-Yoon Kang |
Apr. 12. 21 |
4073 |
Cocktail Therapy for Unusual Calcified Lesion , the Road to Success |
Alan Chan |
Apr. 12. 21 |
4072 |
When and Why OAS Works Better for Calcified Lesions ? |
Michael S. Lee |
Apr. 12. 21 |
4071 |
My Most Frightening Rotablation Case |
Yoshifumi Kashima |
Apr. 12. 21 |
4070 |
Functional MR - Percutaneous Treatment Considerations |
Samir R. Kapadia |
Apr. 12. 21 |